Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in IHE
40.5%
% of IHE's 38 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.3% | 22.2% | 7.3% |
|
BRISTOL-MYERS SQUIBB CO | 8.8% | 5.5% | 5.5% |
|
VIATRIS, INC. | 4.2% | 5.4% | 4.2% |
|
MERCK & CO. INC. | 6.4% | 4.0% | 4.0% |
|
PFIZER INC | 6.7% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to IHE
|
ABBVIE INC | 6.6% |
|
GILEAD SCIENCES INC | 4.4% |
|
CARDINAL HEALTH INC | 4.1% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
AMGEN INC | 3.3% |
|
BRISTOL-MYERS SQUIBB CO | 3.3% |
|
BIOGEN IDEC INC | 3.1% |
|
PFIZER INC | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.5% |
|
CHARLES RIVER LABORATORIES | 2.4% |
FTXH Underweight Relative to IHE
|
ELI LILLY & CO | -16.2% |
|
JOHNSON & JOHNSON | -14.9% |
|
CATALENT INC | -4.4% |
|
ROYALTY PHARMA PLC CLASS A | -4.1% |
|
INTRA-CELLULAR THERAPIES INC | -2.8% |
|
AXSOME THERAPEUTICS, INC. | -1.6% |
|
VIATRIS, INC. | -1.2% |
|
CORCEPT THERAPEUTICS INC | -1.2% |
|
ELANCO ANIMAL HEALTH, INC. | -1.0% |
|
LIGAND PHARMACEUTICALS-CL B | -0.8% |